home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

4.030 +0.200 (+5.22%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why Shares of Quanterix Are Climbing This Morning ↗

October 12, 2021

Regulators are helping accelerate an early test for Alzheimer's disease.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 12, 2021

Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million. Inhibrx (...

Via Benzinga

15 Stocks Moving in Tuesday's Pre-Market Session ↗

October 12, 2021

Gainers Quanterix Corporation (NASDAQ: QTRX) shares rose 17.6% to $48.55 in pre-market trading after the company announced its Simoa phospho-Tau 181 blood test has been granted...

Via Benzinga

Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease

October 11, 2021

From Quanterix Corporation

Via Business Wire

Earnings Scheduled For May 5, 2021 ↗

May 05, 2021

Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...

Via Benzinga

Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories

September 20, 2021

From Quanterix Corporation

Via Business Wire

FDA Expands Quanterix's COVID-19 Antigen Test Emergency Use Label ↗

September 14, 2021

The FDA has expanded the Emergency Use Authorization (EUA) label for Quanterix Corporation's (NASDAQ: QTRX) Simoa SARS-CoV-2 N Protein Antigen Test. The...

Via Benzinga

Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test

September 13, 2021

From Quanterix Corporation

Via Business Wire

Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: “COVID-19 Testing in a Residential University Setting: Implementation, Insights, and Learnings”

September 10, 2021

From Quanterix Corporation

Via Business Wire

Return On Capital Employed Insights For Quanterix ↗

September 03, 2021

Benzinga Pro data, Quanterix (NASDAQ:QTRX) reported Q2 sales of $25.37 million. Earnings fell to a loss of $13.67 million, resulting in a 39.63% decrease from last quarter. In Q1...

Via Benzinga

Why Cassava Sciences Is Plunging Again Today ↗

August 27, 2021

More red flags are emerging for this troubled Alzheimer's biotech company.

Via The Motley Fool

Cassava Stock Dives Again As Lab Distances Itself From 'Data Manipulation' Allegations ↗

August 27, 2021

The lab that tested samples for Cassava's Alzheimer's study distanced itself from the biotech Friday, and SAVA stock plunged again.

Via Investor's Business Daily

Why Cassava Sciences Stock Investors Are Pulling Back ↗

August 27, 2021

The neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) hasnow lost half of its market capitalization as skeletons continue to tumble out of...

Via Benzinga

Quanterix Releases Statement

August 27, 2021

From Quanterix Corporation

Via Business Wire

63 Biggest Movers From Yesterday ↗

August 27, 2021

Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11...

Via Benzinga

45 Stocks Moving In Thursday's Mid-Day Session ↗

August 26, 2021

Gainers Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of its stockholders on Friday,...

Via Benzinga

Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference

August 09, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

August 06, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Corporation Releases Operating Results for Second Quarter of 2021

August 05, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021

July 28, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Appoints Michael Doyle as Chief Financial Officer

June 28, 2021

From Quanterix Corporation

Via Business Wire

Medical Device Maker Quanterix Stock Shows Rising Relative Strength ↗

June 11, 2021

On Friday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating upgrading to 91 from 88 a day before.

Via Investor's Business Daily

Quanterix’ Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light’s Role in Dementia Diagnosis

June 07, 2021

From Quanterix Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021 ↗

June 04, 2021

Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high...

Via Benzinga

Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report

June 02, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics

May 11, 2021

From Quanterix Corporation

Via Business Wire

64 Biggest Movers From Yesterday ↗

May 11, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3....

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 10, 2021

Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

Quanterix Corporation Releases Operating Results for First Quarter 2021

May 05, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Corporation to Release First Quarter 2021 Financial Results on May 5, 2021

April 28, 2021

From Quanterix Corporation

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com